Ocuphire Pharma, Inc. — Form D
Ocuphire Pharma, Inc. of Farmington HIlls, MI, a company, filed a Form D exempt-offering notice with the SEC on 2020-02-03. The offering totals $2.1M, of which $2.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-02-03
- Form: D
- Accession: 0001738266-20-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.1M
- Amount sold: $2.1M
- Investors: 4
- Date of first sale: 2020-01-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-359570
Issuer
- Name: Ocuphire Pharma, Inc.
- CIK: 0001738266
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 37000 Grand River Ave, Farmington HIlls, MI, 48335
- Phone: 248-681-9815
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Sean Ainsworth | Director | Farmington Hills, MI |
| Cam Gallagher | Director | San Diego, CA |
| James Manuso | Director | TAMPA, FL |
| Alan Meyer | Director | Farmington HIlls, MI |
| Mina Sooch | Director | Farmington Hills, MI |
| Bernhard Hoffmann | Executive Officer | Farmington Hills, MI |
| Mina Sooch | Executive Officer | Farmington Hills, MI |
| Meyer Alan | Director | West Bloomfield, MI |
Other filings by this issuer (3)
More